In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis

被引：0
|
作者：
Lens, Sabela [1 ]
机构：
[1] Univ Barcelona, Liver Unit Hosp Clin, Barcelona, Spain
来源：
GASTROENTEROLOGY | 2024年 / 167卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：623 / 624
页数：2
相关论文
共 50 条
  • [31] UK second-line paediatric primary ITP therapy analysis
    Chaudhury, Bobby
    Grainger, John
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (09) : 929 - 931
  • [32] SECOND-LINE THERAPY IS INDICATED IN URSODEOXYCHOLIC ACID-TREATED PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HIGH ALKALINE PHOSPHATASE DESPITE A COMPLETE GLOBE-SCORE RESPONSE
    de Veer, Rozanne
    Harms, Maren H.
    Corpechot, Christophe
    Lammers, Willem J.
    Thorburn, Douglas
    Invernizzi, Pietro
    Janssen, Harry L. A.
    Battezzati, Pier Maria
    Nevens, Frederik
    Lindor, Keith D.
    Floreani, Annarosa
    Ponsioen, Cyriel
    Mayo, Marlyn J.
    Pares, Albert
    Mason, Andrew L.
    Kowdley, Kris V.
    Trivedi, Palak J.
    Hirschfield, Gideon
    Bruns, Tony
    Dalekos, George N.
    Verhelst, Xavier
    Hansen, Bettina E.
    Van Buuren, Henk R.
    Van der Meer, Adriaan
    HEPATOLOGY, 2019, 70 : 783A - 785A
  • [33] LONG-TERM USE OF FENOFIBRATE AS SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS: A RETROSPECTIVE 12-YEAR STUDY OF CHOLESTATIC MARKERS AND LIVER STIFFNESS MEASUREMENT
    Maxwell, Mariko
    Cristoferi, Laura
    Xu, Yunshan
    Chen, Bonnie
    Xu, Yunshan
    Carbone, Marco
    Silveira, Marina
    Boyer, James
    Assis, David
    HEPATOLOGY, 2024, 80 : S1792 - S1793
  • [34] BEZAFIBRATE AS SECOND LINE TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: A REAL WORLD EXPERIENCE
    McCabe, Rebecca
    Prince, Martin
    Greer, Shaun
    Dhaliwal, Harpreet
    GUT, 2021, 70 : A147 - A147
  • [35] Second-line therapy in advanced biliary tract cancer: What should be the standard?
    Cereda, Stefano
    Belli, Carmen
    Rognone, Alessia
    Mazza, Elena
    Reni, Michele
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (02) : 368 - 374
  • [36] Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices
    Cuker, Adam
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (06) : 816 - 823
  • [37] Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy
    Su, Xiaole
    Wu, Binxin
    Tie, Xuan
    Guo, Xiaojiao
    Feng, Rongrong
    Qiao, Xi
    Wang, Lihua
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (08): : 2386 - 2398
  • [38] Current and promising therapy for primary biliary cholangitis
    Gossard, Andrea A.
    Lindor, Keith D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (09) : 1161 - 1167
  • [39] Primary biliary cholangitis: Old and novel therapy
    Floreani, Annarosa
    Mangini, Chiara
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 47 : 1 - 5
  • [40] Combination therapy with capecitabine and cisplatin as second-line chemotherapy for advanced biliary tract cancer
    Jung, Jang Han
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Park, Jeong Youp
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 210 - 210
12345